|
S.V. Malchikova, N.Yu. Lobanova, E.N. Chicherina, N.S. Maksimchuk-Kolobova
Clinical and economic efficiency of the coronary calcium score assessment in choosing a primary prevention strategy
|
№1 / 2025
|
|
E.V. Biryukova, M.V. Shinkin, I.A. Morozovа
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
|
№3 / 2023
|
|
E.A. Koltsova, E.A. Petrova, V.V. Grechenko, L.V. Gankovskaya
Changes in TLR2 and TLR4 gene expression in patients with ischemic stroke
|
№13 / 2022
|
|
A.F. Verbovoy, Yu.A. Dolgikh, N.I. Verbovaya, T.V. Lomonova
Obesity: an invisible disease
|
№12 / 2021
|
|
K.V. Antonova (1), M.M. Tanashyan (1), M.Yu. Maksimova (1), N.V. Shakhparonova (1), T.I. Romantsova (2)
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
|
№4 / 2019
|
|
O.V. Chernichuk (1), O.V. Lyang (1, 2, 3), A.G. Kochetov (1, 2, 3), N.A. Shamalov (3), L.V. Stakhovskaya (3)
ETIOLOGICAL ROLE OF OXIDIZED LOW-DENSITY LIPOPROTEINS IN THE DEVELOPMENT OF ISCHEMIC STROKE
|
№5 / 2018
|
|
M.Kh. Shurdumova, E.V. Konstantinova, N.A. Shostak
EXPRESSION OF TOLL-LIKE RECEPTORS-4 BY PERIPHERAL BLOOD CELLS IN PATIENTS WITH MYOCARDIAL INFARCTION AND ISCHEMIC STROKE
|
№9 / 2017
|
|
E.V. Mitroshina, A.F. Verbovoy
OSTEOPOROSIS AND ATHEROSCLEROSIS: WHAT IS THE GENERAL?
|
№19 / 2015
|
|
V.S. Nikiforov
BLOOD VISCOSITY AS A TARGET OF THERAPEUTIC INTERVENTION IN CARDIOVASCULAR PATHOLOGY
|
№13 / 2015
|
|
E.I. Astashkin, M.G. Glezer
DISCIRCULATORY ENCEPHALOPATHY: CLINICAL FEATURES, DIAGNOSIS AND TREATMENT OPTIONS
|
№9 / 2015
|
|
N.I. Verbovaya,I.Yu. Kapralova, A.F. Verbovoy
ADIPONECTIN, LEPTIN, AND OTHER METABOLIC PARAMETERS IN PATIENTS WITH HYPOTHYROIDISM
|
№10 / 2014
|
|
L.A. Strizhakov, S.V.Moiseev, E.N. Semenkova, E.A. Cogan, S.P. Pasha, E.I. Kuznetsova, V.E. Ditterle, N.A. Mukhin
CLINICAL PATHOMORPHOLOGICAL VERSIONS OF HEART DISEASE IN PATIENTS WITH SYSTEMIC VASCULITIS AND FEATURES OF NON-INVASIVE DIAGNOSTIC METHODS
|
№9 / 2013
|
Русский
